INO-3107 Immunotherapy Shows Benefit in Recurrent Respiratory Papillomatosis
RRP Researcher's paper claims no additional trial study is necessary to approve 3107, results of currently available studies are sufficient to prove 3107s superiority over PGEN's gorilla adenovirus
u/tomonota — 10 days ago